ADALIMUMAB
adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes
ADALIMUMAB (13721E)
13721E
Manner of administration:Injection
Restriction (Streamlined authority code: 14567)
Indication: Severe active rheumatoid arthritis
Treatment phase: First continuing treatment
